Mitigating contrast-induced acute kidney injury associated with cardiac catheterization

Mark Nunag, Maureen Brogan, Renee Garrick

Research output: Contribution to journalReview article

14 Scopus citations

Abstract

Contrast-induced nephropathy, also referred to as contrast-induced acute kidney injury (CIAKI), is among the most common causes of AKI, especially in patients with underlying chronic kidney disease. In addition to the increased cost engendered by the development of CIAKI, several studies have suggested the occurrence of AKI after cardiac procedures is associated with an increase in both morbidity and mortality. This increase in morbidity and mortality occurs after both intravenous and intra-arterial studies. This review focuses on relevant proposed pathophysiological mechanisms, risk factors, and current prophylactic strategies, which may reduce the incidence of CIAKI during cardiac angiographic imaging studies.

Original languageEnglish (US)
Pages (from-to)263-269
Number of pages7
JournalCardiology in review
Volume17
Issue number6
DOIs
StatePublished - Nov 1 2009
Externally publishedYes

Keywords

  • Bicarbonate therapy
  • Cardiac angiography
  • Contrast-induced AKI
  • Contrast-induced nephropathy
  • N-acetylcysteine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Mitigating contrast-induced acute kidney injury associated with cardiac catheterization'. Together they form a unique fingerprint.

  • Cite this